Writing group member	Employment	Research grant	Other research support	Speakers’ bureau/honoraria	Expert witness	Ownership interest	Consultant/advisory board	Other
Gervasio A. Lamas	Columbia University, Mount Sinai Medical Center	NIH grants managed by Mount Sinai†	None	None	None	None	None	Columbia University Irving Medical Center (Professor)†
Ana Navas‐Acien	Columbia University	NIH (several NIH grants managed by Columbia University)†	None	None	None	None	None	Columbia University (professor)†
Aruni Bhatnagar	University of Louisville	None	None	None	None	None	None	None
Miranda R. Jones	Johns Hopkins Bloomberg School of Public Health	None	None	None	None	None	None	None
Koren K. Mann	McGill University (Canada)	None	None	None	None	None	None	None
Khurram Nasir	Houston Methodist	None	None	None	None	None	None	None
Maria Tellez‐Plaza	Instituto de Salud Carlos III, Spain	Intramural funds for research in health sciences, Instituto de Salud Carlos III, Spain, managed by Instituto de Salud Carlos III*	None	None	None	None	None	Universidad Autonoma de Madrid (Adjunct Associate Professor)*
Francisco Ujueta	Mount Sinai Medical Center	None	None	None	None	None	None	None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12‐month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

^†Significant.